id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-270258-9vgpphiu	Ko, Jae-Hoon	Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients	2016-08-09		.txt	text/plain	3461	133	38	World Health Organization Case definition and management of patients with MERS coronavirus in Saudi Arabia MERS-CoV outbreak in Jeddah e a link to health care facilities On estimating the relation between blood group and disease Treatment outcomes for patients with Middle Eastern respiratory syndrome coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia Treatment strategies for Middle East respiratory syndrome coronavirus Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV), US CDC Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong White cell differential count and influenza A Thrombocytopenia in patients with severe acute respiratory syndrome (review) The clinical course of symptomatic MERS patients progressed serially: patients developed initial symptoms after a median 5-day incubation period (IQR 3.5e7.0), pneumonia after a median of 6 days from symptom onset (IQR 5.0e7.0), and respiratory failure after a median of 12 days from symptom onset (IQR 10.0e13.0).	cache/cord-270258-9vgpphiu.txt	txt/cord-270258-9vgpphiu.txt
